Home / Compare / Eden vs Mochi
Eden vs Mochi Health (2026): the mid-band head-to-head — footprint versus fee dispute
Eden and Mochi occupy the compounded market's middle band for different reasons. Eden reports $249–296/month with the widest reported state footprint we track (~50 states via its platform pharmacies) — the common answer when licensure walls block cheaper programs. Mochi advertises flat medication pricing but requires a membership whose size our sources dispute — ~$79 versus ~$149/month — putting effective cost near ~$278; we publish both figures rather than average them. Annualized: Eden ~$2,988–3,552, Mochi ~$3,336. Pick Eden when your state is the constraint; pick Mochi only after its membership number is confirmed at your checkout — and note that both cost $1,300+ more per year than the unverified floor and within ~$1,600 of brand vials, which is the band's structural problem.
Eden's case: availability as the product
Eden's differentiation isn't price — it's reach. In a market where "we can't ship to your state" is the most common dead end (the licensure mechanics in our state guide), a ~50-state reported footprint is a real feature, and Eden is the name that keeps appearing when Californians and other thin-state readers report success. The honest caveats: the footprint claim is reported, not license-verified by us — it sits in the dataset's open items — and multi-pharmacy platforms mean your vial's source and concentration can vary, which makes the units-recalculation ritual from the dosage chart non-optional at every shipment. At $249–296 all-in reported, Eden prices availability at roughly $80–150/month over the reported budget tier; whether that's worth it depends entirely on whether the budget tier can legally reach you.
Mochi's case: structure, undermined by one disputed number
Mochi built its brand on transparent, flat medication pricing — and then attached a required membership whose reported size varies by nearly two-to-one across sources. We refuse to average disputes: both the ~$79 and ~$149 figures sit in the fact sheet with their sources, effective cost lands near $278 either way at the medication tier most cited, and the discrepancy itself is the review — a pricing-transparency brand whose true monthly cost can't be stated without a range has a homework item only its own checkout can close. If Mochi's structure appeals, the purchase protocol is simple: screenshot the membership line at checkout, confirm whether medication pricing truly holds flat across your titration, and send the receipt to corrections — one reader screenshot resolves what three aggregators couldn't.
The verdict, and the band's bigger problem
Eden wins when geography is your binding constraint — that's its product. Mochi wins for buyers who value flat medication pricing and confirm the membership at their own checkout. But zoom out and the mid-band's structural squeeze is the real finding: at ~$3,000–3,550 a year, both programs sit $1,300+ above the (unverified) operator floor and only ~$1,400–2,000 below FDA-approved LillyDirect vials at $299–449 — a shrinking corridor where "compounded but premium" has to justify itself against brand certainty above and cheaper claims below. The consensus map shows every ranking wrestling with the same squeeze; our answer is the same as always — statuses, receipts, and the finder.
Related: NexLife vs Mochi · Mochi vs Orderly · the under-$200 test
Reach versus arithmetic: making the call with your own zip code
This matchup decides on two lookups. First, coverage: check whether Mochi serves your state and — the sharper question — whether the cheaper tier below both (the $119–199 programs on the state map) does; Eden's premium is rational only where thinner programs aren't licensed, because reach is its entire product. Second, arithmetic: Eden's $249–296 is at least clean, while Mochi's true total is the market's most public dispute — three circulating versions of its membership fee put effective costs anywhere from ~$249 to ~$278+ — so a Mochi decision requires the checkout-line-item screenshot its verification file keeps requesting. Structural notes that survive both lookups: Mochi's flat medication pricing is a genuine titration advantage if the membership math clears; Eden's multi-pharmacy fulfillment is a genuine logistics advantage that carries the every-vial units-recalculation duty. If both lookups clear and the totals tie, prefer whichever structure matches your risk: single-platform continuity (Eden) versus flat-price predictability (Mochi) — and if the cheaper tier serves you, this whole comparison was the wrong page, happily.
Head-to-head FAQ
Is Eden or Mochi cheaper?
On published figures they can land within dollars of each other — Eden at $249–296, Mochi at ~$249–278+ depending on which membership-fee version is current. Mochi's checkout line items are the tiebreaker its own dispute demands.
Why choose Eden over cheaper programs?
Reach — its multi-pharmacy model serves states the $119–199 tier often doesn't. If a cheaper verified program is licensed in your state, Eden's premium buys little.
Does Mochi's membership fee apply on top of medication?
That's the disputed fact: sources cite ~$79, ~$149, and one recent comparison lists pricing with no membership noted. Screenshot your checkout total — we'll publish it within 48 hours.